血圧障害治療薬の世界市場:規模・現状・予測2019-2025

【英語タイトル】Global Blood Pressure Disorders Drug Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR20FB11008)・商品コード:QYR20FB11008
・発行会社(調査会社):QYResearch
・発行日:2019年12月
・ページ数:152
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥413,400見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥620,100見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥826,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、血圧障害治療薬の世界市場について調査・分析し、血圧障害治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、アンジオテンシン受容体遮断薬(ARB)、その他)、用途別(高血圧、低血圧、肺高血圧)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の血圧障害治療薬市場動向
・主要企業別マーケットシェア
・血圧障害治療薬の種類別市場規模2014-2019
(利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、アンジオテンシン受容体遮断薬(ARB)、その他)
・血圧障害治療薬の用途別市場規模2014-2019
(高血圧、低血圧、肺高血圧)
・血圧障害治療薬の北米市場:主要企業・種類別/用途別市場規模
・血圧障害治療薬のヨーロッパ市場:主要企業・種類別/用途別市場規模
・血圧障害治療薬の中国市場:主要企業・種類別/用途別市場規模
・血圧障害治療薬の日本国内市場:主要企業・種類別/用途別市場規模
・血圧障害治療薬の東南アジア市場:主要企業・種類別/用途別市場規模
・血圧障害治療薬のインド市場:主要企業・種類別/用途別市場規模
・血圧障害治療薬の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(A1M Pharma AB、Acceleron Pharma Inc、Ache Laboratorios Farmaceuticos SA、Actelion Pharmaceuticals Ltd、Aerogen Ltd、Anavex Life Sciences Corp、AnGes Inc、Arena Pharmaceuticals Inc、Ascendia Pharmaceuticals LLC、Ascendis Pharma A/S、AVEO Pharmaceuticals Inc、Bayer AG、Bial - Portela & Ca SA、Bioblue Technologies Inc、Biogen Inc、Biolab Farmaceutica Ltda、BioRestorative Therapies Inc、Boryung Pharmaceutical Co Ltd、Bristol-Myers Squibb Co、Camurus AB、Capricor Therapeutics Inc、Celsion Corp、Celtaxsys Inc、Chiesi Farmaceutici SpA、Chong Kun Dang Pharmaceutical Corp、Chugai Pharmaceutical Co Ltd、CJ HealthCare Corp、Complexa Inc、Corion Biotech Srl)
・血圧障害治療薬の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Blood pressure disorder drug development technology and related unitsHigh blood pressure, also known as high blood pressure, is a condition in which arterial blood pressure continues to rise. Many factors affect blood pressure, including hormone levels in the body, water and salt levels, and kidney, nervous system and blood vessels.
Most hypertensive patients do not have any signs or symptoms even if their blood pressure readings reach dangerously high levels. Although a small number of people with early-onset hypertension may experience dizziness, dizziness, or more nosebleeds than normal, these symptoms and symptoms usually do not occur until the high blood pressure reaches a critical stage. There are currently 253 products under development.
In 2018, the global Blood Pressure Disorders Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Blood Pressure Disorders Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Blood Pressure Disorders Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen Ltd
Anavex Life Sciences Corp
AnGes Inc
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer AG
Bial – Portela & Ca SA
Bioblue Technologies Inc
Biogen Inc
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics Inc
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co Ltd
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl

Market segment by Type, the product can be split into
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Others

Market segment by Application, split into
Hypertension
Hypotension
Pulmonary Hypertension

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Blood Pressure Disorders Drug status, future forecast, growth opportunity, key market and key players.
To present the Blood Pressure Disorders Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Blood Pressure Disorders Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Blood Pressure Disorders Drug Market Size Growth Rate by Type (2014-2025)
1.4.2 Diuretics
1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.4.4 Angiotensin Receptor Blockers (ARBs)
1.4.5 Others
1.5 Market by Application
1.5.1 Global Blood Pressure Disorders Drug Market Share by Application (2019-2025)
1.5.2 Hypertension
1.5.3 Hypotension
1.5.4 Pulmonary Hypertension
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Blood Pressure Disorders Drug Market Size
2.2 Blood Pressure Disorders Drug Growth Trends by Regions
2.2.1 Blood Pressure Disorders Drug Market Size by Regions (2019-2025)
2.2.2 Blood Pressure Disorders Drug Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Blood Pressure Disorders Drug Market Size by by Players
3.1.1 Global Blood Pressure Disorders Drug Revenue by by Players (2014-2019)
3.1.2 Global Blood Pressure Disorders Drug Revenue Market Share by by Players (2014-2019)
3.1.3 Global Blood Pressure Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.2 Blood Pressure Disorders Drug Key Players Head office and Area Served
3.3 Key Players Blood Pressure Disorders Drug Product/Solution/Service
3.4 Date of Enter into Blood Pressure Disorders Drug Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Blood Pressure Disorders Drug Market Size by Type (2014-2019)
4.2 Global Blood Pressure Disorders Drug Market Size by Application (2014-2019)

5 North America
5.1 North America Blood Pressure Disorders Drug Market Size (2014-2019)
5.2 Blood Pressure Disorders Drug Key Players in North America
5.3 North America Blood Pressure Disorders Drug Market Size by Type
5.4 North America Blood Pressure Disorders Drug Market Size by Application

6 Europe
6.1 Europe Blood Pressure Disorders Drug Market Size (2014-2019)
6.2 Blood Pressure Disorders Drug Key Players in Europe
6.3 Europe Blood Pressure Disorders Drug Market Size by Type
6.4 Europe Blood Pressure Disorders Drug Market Size by Application

7 China
7.1 China Blood Pressure Disorders Drug Market Size (2014-2019)
7.2 Blood Pressure Disorders Drug Key Players in China
7.3 China Blood Pressure Disorders Drug Market Size by Type
7.4 China Blood Pressure Disorders Drug Market Size by Application

8 Japan
8.1 Japan Blood Pressure Disorders Drug Market Size (2014-2019)
8.2 Blood Pressure Disorders Drug Key Players in Japan
8.3 Japan Blood Pressure Disorders Drug Market Size by Type
8.4 Japan Blood Pressure Disorders Drug Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Blood Pressure Disorders Drug Market Size (2014-2019)
9.2 Blood Pressure Disorders Drug Key Players in Southeast Asia
9.3 Southeast Asia Blood Pressure Disorders Drug Market Size by Type
9.4 Southeast Asia Blood Pressure Disorders Drug Market Size by Application

10 India
10.1 India Blood Pressure Disorders Drug Market Size (2014-2019)
10.2 Blood Pressure Disorders Drug Key Players in India
10.3 India Blood Pressure Disorders Drug Market Size by Type
10.4 India Blood Pressure Disorders Drug Market Size by Application

11 Central & South America
11.1 Central & South America Blood Pressure Disorders Drug Market Size (2014-2019)
11.2 Blood Pressure Disorders Drug Key Players in Central & South America
11.3 Central & South America Blood Pressure Disorders Drug Market Size by Type
11.4 Central & South America Blood Pressure Disorders Drug Market Size by Application

12 International Players Profiles
12.1 A1M Pharma AB
12.1.1 A1M Pharma AB Company Details
12.1.2 Company Description and Business Overview
12.1.3 Blood Pressure Disorders Drug Introduction
12.1.4 A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2014-2019))
12.1.5 A1M Pharma AB Recent Development
12.2 Acceleron Pharma Inc
12.2.1 Acceleron Pharma Inc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Blood Pressure Disorders Drug Introduction
12.2.4 Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2014-2019)
12.2.5 Acceleron Pharma Inc Recent Development
12.3 Ache Laboratorios Farmaceuticos SA
12.3.1 Ache Laboratorios Farmaceuticos SA Company Details
12.3.2 Company Description and Business Overview
12.3.3 Blood Pressure Disorders Drug Introduction
12.3.4 Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2014-2019)
12.3.5 Ache Laboratorios Farmaceuticos SA Recent Development
12.4 Actelion Pharmaceuticals Ltd
12.4.1 Actelion Pharmaceuticals Ltd Company Details
12.4.2 Company Description and Business Overview
12.4.3 Blood Pressure Disorders Drug Introduction
12.4.4 Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2014-2019)
12.4.5 Actelion Pharmaceuticals Ltd Recent Development
12.5 Aerogen Ltd
12.5.1 Aerogen Ltd Company Details
12.5.2 Company Description and Business Overview
12.5.3 Blood Pressure Disorders Drug Introduction
12.5.4 Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2014-2019)
12.5.5 Aerogen Ltd Recent Development
12.6 Anavex Life Sciences Corp
12.6.1 Anavex Life Sciences Corp Company Details
12.6.2 Company Description and Business Overview
12.6.3 Blood Pressure Disorders Drug Introduction
12.6.4 Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2014-2019)
12.6.5 Anavex Life Sciences Corp Recent Development
12.7 AnGes Inc
12.7.1 AnGes Inc Company Details
12.7.2 Company Description and Business Overview
12.7.3 Blood Pressure Disorders Drug Introduction
12.7.4 AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2014-2019)
12.7.5 AnGes Inc Recent Development
12.8 Arena Pharmaceuticals Inc
12.8.1 Arena Pharmaceuticals Inc Company Details
12.8.2 Company Description and Business Overview
12.8.3 Blood Pressure Disorders Drug Introduction
12.8.4 Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2014-2019)
12.8.5 Arena Pharmaceuticals Inc Recent Development
12.9 Ascendia Pharmaceuticals LLC
12.9.1 Ascendia Pharmaceuticals LLC Company Details
12.9.2 Company Description and Business Overview
12.9.3 Blood Pressure Disorders Drug Introduction
12.9.4 Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2014-2019)
12.9.5 Ascendia Pharmaceuticals LLC Recent Development
12.10 Ascendis Pharma A/S
12.10.1 Ascendis Pharma A/S Company Details
12.10.2 Company Description and Business Overview
12.10.3 Blood Pressure Disorders Drug Introduction
12.10.4 Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2014-2019)
12.10.5 Ascendis Pharma A/S Recent Development
12.11 AVEO Pharmaceuticals Inc
12.12 Bayer AG
12.13 Bial – Portela & Ca SA
12.14 Bioblue Technologies Inc
12.15 Biogen Inc
12.16 Biolab Farmaceutica Ltda
12.17 BioRestorative Therapies Inc
12.18 Boryung Pharmaceutical Co Ltd
12.19 Bristol-Myers Squibb Co
12.20 Camurus AB
12.21 Capricor Therapeutics Inc
12.22 Celsion Corp
12.23 Celtaxsys Inc
12.24 Chiesi Farmaceutici SpA
12.25 Chong Kun Dang Pharmaceutical Corp
12.26 Chugai Pharmaceutical Co Ltd
12.27 CJ HealthCare Corp
12.28 Complexa Inc
12.28 Corion Biotech Srl

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details



【掲載企業】

A1M Pharma AB、Acceleron Pharma Inc、Ache Laboratorios Farmaceuticos SA、Actelion Pharmaceuticals Ltd、Aerogen Ltd、Anavex Life Sciences Corp、AnGes Inc、Arena Pharmaceuticals Inc、Ascendia Pharmaceuticals LLC、Ascendis Pharma A/S、AVEO Pharmaceuticals Inc、Bayer AG、Bial - Portela & Ca SA、Bioblue Technologies Inc、Biogen Inc、Biolab Farmaceutica Ltda、BioRestorative Therapies Inc、Boryung Pharmaceutical Co Ltd、Bristol-Myers Squibb Co、Camurus AB、Capricor Therapeutics Inc、Celsion Corp、Celtaxsys Inc、Chiesi Farmaceutici SpA、Chong Kun Dang Pharmaceutical Corp、Chugai Pharmaceutical Co Ltd、CJ HealthCare Corp、Complexa Inc、Corion Biotech Srl

★調査レポート[血圧障害治療薬の世界市場:規模・現状・予測2019-2025] (コード:QYR20FB11008)販売に関する免責事項を必ずご確認ください。
★調査レポート[血圧障害治療薬の世界市場:規模・現状・予測2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆